ES2196197T3 - Derivados de benzamida con propiedades inhibidoras de trombina. - Google Patents

Derivados de benzamida con propiedades inhibidoras de trombina.

Info

Publication number
ES2196197T3
ES2196197T3 ES96944604T ES96944604T ES2196197T3 ES 2196197 T3 ES2196197 T3 ES 2196197T3 ES 96944604 T ES96944604 T ES 96944604T ES 96944604 T ES96944604 T ES 96944604T ES 2196197 T3 ES2196197 T3 ES 2196197T3
Authority
ES
Spain
Prior art keywords
alkyl
halogen
alkoxy
optionally substituted
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96944604T
Other languages
English (en)
Inventor
Nigel Stephen Watson
Martin Pass
Vipulkumar Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2196197T3 publication Critical patent/ES2196197T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto representado por la fórmula (I)**fórmula** donde R1 y R2 representan independientemente un grupo o R1 y R2 forman juntos un grupo heterocicloalquilo o heterocicloalquenilo C3-7, que puede estar opcionalmente sustituido con alquilo C1-6, alcoxi C1-4, halógeno, ácido carboxílico o un grupo éster de ácido carboxílico C1-4; R3 representa hidrógeno, alquilo C1-3, halógeno, o alcoxi C1-2; R4, R5 y R6 representan independientemente hidrógeno, o halógeno; R7 representa hidrógeno o alquilo C1-6; R8 representa hidrógeno, cicloalquilo C3-7, cicloalquenilo C3-7, heterocicloalquilo C3-7, heterocicloalquenilo C3-7, fenilo, naftilo, un anillo heterocíclico aromático de 5 ó 6 miembros que contiene uno o más heteroátomos seleccionados de átomos de nitrógeno, azufre y oxígeno, o un sistema bicíclico de anillos condensados que contiene uno o más átomos de nitrógeno, azufre y oxígeno, grupos que opcionalmente están sustituidos con uno o más grupos seleccionados de halógeno, hidroxi, CN, alquilo C1-6, alcoxi C1-6, aciloxi C1-6, NR9R10, NHCOR11, NHSO2R12, COR13, CO2R14, CONR15R16, y SO2NHR17.
ES96944604T 1995-12-15 1996-12-13 Derivados de benzamida con propiedades inhibidoras de trombina. Expired - Lifetime ES2196197T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9525620.2A GB9525620D0 (en) 1995-12-15 1995-12-15 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2196197T3 true ES2196197T3 (es) 2003-12-16

Family

ID=10785445

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96944604T Expired - Lifetime ES2196197T3 (es) 1995-12-15 1996-12-13 Derivados de benzamida con propiedades inhibidoras de trombina.

Country Status (8)

Country Link
US (1) US6326386B1 (es)
EP (1) EP1021411B1 (es)
AT (1) ATE233733T1 (es)
AU (1) AU1303097A (es)
DE (1) DE69626554T2 (es)
ES (1) ES2196197T3 (es)
GB (1) GB9525620D0 (es)
WO (1) WO1997022589A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821483D0 (en) 1998-10-03 1998-11-25 Glaxo Group Ltd Chemical compounds
TW499412B (en) 1996-11-26 2002-08-21 Dimensional Pharm Inc Aminoguanidines and alkoxyguanidines as protease inhibitors
US6344486B1 (en) 1998-04-03 2002-02-05 3-Dimensional Pharmaceuticals, Inc. Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
AR023819A1 (es) * 1999-05-03 2002-09-04 Astrazeneca Ab FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION
WO2001017947A1 (fr) * 1999-09-06 2001-03-15 Takeda Chemical Industries, Ltd. Procedes de preparation de composes 2,3-dihydroazepine
KR20030022353A (ko) 2000-08-04 2003-03-15 3-디멘져널 파마슈티칼즈 인코오포레이티드 사이클릭 옥시구아니딘 프로테아제 저해제
GB0117144D0 (en) * 2001-07-13 2001-09-05 Glaxo Group Ltd Process
JP2006526017A (ja) * 2003-05-14 2006-11-16 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
US8697387B2 (en) * 2006-06-02 2014-04-15 DiscoverRx Corporation Methods for identifying agents and their use for the prevention of restenosis
AU2012252165A1 (en) 2011-05-09 2013-03-21 Cambridge Enterprise Limited Methods of modulating micrornas in the treatment of pulmonary arterial hypertension
JP6738326B2 (ja) * 2014-06-06 2020-08-12 ザ スクリプス リサーチ インスティテュート フッ化硫黄（ｖｉ）化合物およびそれの製造方法
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW257757B (es) * 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
WO1994022834A1 (en) * 1993-03-29 1994-10-13 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors

Also Published As

Publication number Publication date
US6326386B1 (en) 2001-12-04
WO1997022589A1 (en) 1997-06-26
GB9525620D0 (en) 1996-02-14
DE69626554T2 (de) 2004-02-12
EP1021411B1 (en) 2003-03-05
EP1021411A1 (en) 2000-07-26
ATE233733T1 (de) 2003-03-15
DE69626554D1 (de) 2003-04-10
AU1303097A (en) 1997-07-14

Similar Documents

Publication Publication Date Title
ES2196197T3 (es) Derivados de benzamida con propiedades inhibidoras de trombina.
PT1052254E (pt) Derivados heterocíclicos azotados e medicamento dos mesmos
DE60209497D1 (de) Schmierölzusammensetzung enthaltend ein gemisch aus carboxylsäuren und aminen als rostschutzmittel
DK1563032T3 (da) Sammensætninger, der indeholder floursubstituerede olefiner
DE60332350D1 (de) Disazofarbstoffe und sie enthaltende tintenstrahldrucktinten
EA200201071A1 (ru) Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы
CO5031250A1 (es) Compuesto farmaceutico
ATE425145T1 (de) Verwendung von 4-cyanonaphthalin-1, 8- dicarbonsäureimidderivaten und verwandten verbindungen zum schützen von organischem material gegen die schädigenden einwirkungen von licht
DE60223904D1 (de) Benzylaminanalogen
EP1306369A4 (en) NEW SULFUR COMPOUNDS AND INTERMOLECULAR COMPOUNDS CONTAINING THEM AS A COMPONENT
DE69734952D1 (de) Anilide als ACAT-Hemmer
DE60220997D1 (de) N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält
DE60230273D1 (de) Flüssigkristallverbindungen
DE60041001D1 (de) Substituierte homopiperidylbenzimidazolanaloga als fundusrelaxantien
ATE328954T1 (de) Stabilisatormischung
DK0702669T3 (da) Hidtil ukendte antivirale midler
DE60139053D1 (de) Verfahren zur herstellung von estern der amicsäure
DE60222281D1 (de) Zusammensetzung
DE69527854D1 (de) Derivate substituierter amidinonaphthylester
BR0317151A (pt) Misturas de agentes de branqueamento fluorescentes
ATE461169T1 (de) Verfahren zur inhibierung der verfärbung von methylenbisanilinverbindungen
ATE123033T1 (de) Luciferinderivate.